BPC 157: Experimental Peptide Creates Risk for Athletes FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner BPC 157: What Research Shows (and What It Doesn't) Meeting Point Health RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion